BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16259575)

  • 21. Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis.
    Lorillon G; Bergeron A; Detourmignies L; Jouneau S; Wallaert B; Frija J; Tazi A
    Am J Respir Crit Care Med; 2012 Nov; 186(9):930-2. PubMed ID: 23118088
    [No Abstract]   [Full Text] [Related]  

  • 22. Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma.
    Shamsian BS; Goudarzipour K; Alavi S; Jadali F; Gharib A; Aghakhani R; Arzanian MT; Rezaei N
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e245-6. PubMed ID: 20628318
    [No Abstract]   [Full Text] [Related]  

  • 23. Excellent remission rates with limited toxicity in relapsed/refractory Langerhans cell histiocytosis with pulse dexamethasone and lenalidomide in children.
    Uppuluri R; Ramachandrakurup S; Subburaj D; Bakane A; Raj R
    Pediatr Blood Cancer; 2017 Jan; 64(1):110-112. PubMed ID: 27555565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy in histiocytosis X.
    Komp DM; Vietti TJ; Berry DH; Starling KA; Haggard ME; George SL
    Med Pediatr Oncol; 1977; 3(3):267-73. PubMed ID: 311409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk organ + LCH gets the one-two punch?
    Stine KC
    Blood; 2015 Sep; 126(12):1399-400. PubMed ID: 26384280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Langerhans cell histiocytosis: old disease new treatment.
    Ng-Cheng-Hin B; O'Hanlon-Brown C; Alifrangis C; Waxman J
    QJM; 2011 Feb; 104(2):89-96. PubMed ID: 21084318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A child with both Langerhans and non-Langerhans cell histiocytosis.
    Shani-Adir A; Chou P; Morgan E; Mancini AJ
    Pediatr Dermatol; 2002; 19(5):419-22. PubMed ID: 12383099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Blueberry muffin" rash and large right thigh mass: a unique presentation of Langerhans cell histiocytosis.
    Lau EG; Stepenaskie S; Moran R; Quinn R; Matthew P; Smidt AC
    Dermatol Online J; 2013 Jun; 19(6):18568. PubMed ID: 24011317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Six years relapse-free treatment of a case with Langerhans cell histiocytosis grade III treated with thalidomide and prednisone].
    Li KY; Hu YM; Lü JB
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):865-6. PubMed ID: 23302621
    [No Abstract]   [Full Text] [Related]  

  • 31. EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH.
    Lee DA; Tatevian N; Herring RA; McClain KL
    Pediatr Blood Cancer; 2008 Mar; 50(3):728-30. PubMed ID: 17243127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Langerhans cell histiocytosis of the atlas. A report of three cases.
    Tanaka N; Fujimoto Y; Okuda T; Nakanishi K; Sumida T; Manabe H; Ochi M
    J Bone Joint Surg Am; 2005 Oct; 87(10):2313-7. PubMed ID: 16203899
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of relapsed Langerhans cell histiocytosis by cyclosporin A combined with etoposide and prednisone.
    Körholz D; Janssen G; Göbel U
    Pediatr Hematol Oncol; 1997; 14(5):443-9. PubMed ID: 9267876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine therapy for advanced Langerhans cell histiocytosis.
    Mahmoud HH; Wang WC; Murphy SB
    Blood; 1991 Feb; 77(4):721-5. PubMed ID: 1993215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult Langerhans cell histiocytosis with pulmonary and colorectoanal involvement: a case report.
    Mansour MJ; Mokbel E; Fares E; Maddah J; Nasr F
    J Med Case Rep; 2017 Sep; 11(1):272. PubMed ID: 28942734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed Treatment Response in a Neonate with Multisystem Langerhans Cell Histiocytosis Case report and review of literature.
    Singh A; Mandal A; Singh L; Mishra S; Patel A
    Sultan Qaboos Univ Med J; 2017 May; 17(2):e225-e228. PubMed ID: 28690898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Juvenile multiple xanthogranuloma in a patient with Langerhans cell histiocytosis].
    Pérez-Gala S; Torrelo A; Colmenero I; Contra T; Madero L; Zambrano A
    Actas Dermosifiliogr; 2006 Nov; 97(9):594-8. PubMed ID: 17173766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult Langerhans cell histiocytosis in a middle aged Ethiopian woman.
    Idriss MH; Temam F; Woldeyes M
    Ethiop Med J; 2012 Apr; 50(2):193-200. PubMed ID: 22924288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adult multi-organ Langerhans cell histiocytosis with fatal outcome].
    Chaabane H; Meziou TJ; Amouri M; Ayadi L; Boudawara T; Elloumi M; Turki H
    Ann Dermatol Venereol; 2013 May; 140(5):410-3. PubMed ID: 23663722
    [No Abstract]   [Full Text] [Related]  

  • 40. Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications.
    Zinn DJ; Chakraborty R; Allen CE
    Oncology (Williston Park); 2016 Feb; 30(2):122-32, 139. PubMed ID: 26888790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.